IL161455A0 - Sterile, breathable patch for treating wound pain - Google Patents

Sterile, breathable patch for treating wound pain

Info

Publication number
IL161455A0
IL161455A0 IL16145502A IL16145502A IL161455A0 IL 161455 A0 IL161455 A0 IL 161455A0 IL 16145502 A IL16145502 A IL 16145502A IL 16145502 A IL16145502 A IL 16145502A IL 161455 A0 IL161455 A0 IL 161455A0
Authority
IL
Israel
Prior art keywords
sterile
wound pain
treating wound
breathable patch
breathable
Prior art date
Application number
IL16145502A
Other languages
English (en)
Original Assignee
Epicept Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epicept Corp filed Critical Epicept Corp
Publication of IL161455A0 publication Critical patent/IL161455A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A61L2300/436—Inhibitors, antagonists of receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL16145502A 2001-10-19 2002-10-17 Sterile, breathable patch for treating wound pain IL161455A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/045,730 US20030082225A1 (en) 2001-10-19 2001-10-19 Sterile, breathable patch for treating wound pain
PCT/US2002/033195 WO2003034900A2 (fr) 2001-10-19 2002-10-17 Timbre sterile respirant pour le traitement de la douleur au niveau d'une plaie

Publications (1)

Publication Number Publication Date
IL161455A0 true IL161455A0 (en) 2004-09-27

Family

ID=21939552

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16145502A IL161455A0 (en) 2001-10-19 2002-10-17 Sterile, breathable patch for treating wound pain

Country Status (8)

Country Link
US (1) US20030082225A1 (fr)
EP (1) EP1441635A4 (fr)
JP (1) JP2005510488A (fr)
KR (1) KR20040048965A (fr)
CA (1) CA2463309A1 (fr)
IL (1) IL161455A0 (fr)
MX (1) MXPA04003589A (fr)
WO (1) WO2003034900A2 (fr)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6302875B1 (en) 1996-10-11 2001-10-16 Transvascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
WO2003068211A1 (fr) * 2002-02-12 2003-08-21 Cypress Bioscience, Inc. Methodes de traitement du trouble d'hyperactivite avec deficit de l'attention (thada)
US20060177381A1 (en) * 2002-02-15 2006-08-10 Howard Brooks-Korn Opiopathies
US6978174B2 (en) 2002-04-08 2005-12-20 Ardian, Inc. Methods and devices for renal nerve blocking
US8150519B2 (en) 2002-04-08 2012-04-03 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US20080213331A1 (en) 2002-04-08 2008-09-04 Ardian, Inc. Methods and devices for renal nerve blocking
US9636174B2 (en) 2002-04-08 2017-05-02 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US20070129761A1 (en) 2002-04-08 2007-06-07 Ardian, Inc. Methods for treating heart arrhythmia
US20070135875A1 (en) 2002-04-08 2007-06-14 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
DE60306134T2 (de) * 2002-04-24 2007-04-19 Insense Ltd., Sharnbrook Wundauflage enthaltend ein oxidoreduktase-enzym in hydratiertem zustand
US20050008828A1 (en) * 2002-07-25 2005-01-13 Trustees Of Stevens Institute Of Technology Patterned polymer microgel and method of forming same
US20040116470A1 (en) * 2002-12-16 2004-06-17 Nickel Alfred A. Novel use of ion channel active compound, meperidine, to mediate process of accelerated wound healing
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
GB0313217D0 (en) 2003-06-09 2003-07-16 Insense Ltd Improvements in or relating to skin dressings
US20050181026A1 (en) * 2003-06-09 2005-08-18 Insense Limited Skin dressings
US20060014003A1 (en) * 2003-07-24 2006-01-19 Libera Matthew R Functional nano-scale gels
CA2541974A1 (fr) * 2003-10-02 2005-04-14 Trustees Of Stevens Institute Of Technology Capsules de films polymeres neutres a multiples couches associees par liaison d'hydrogene
EP1691745B1 (fr) * 2003-12-11 2011-02-02 Teikoku Pharma USA, Inc. Procedes et compositions pour traiter les plaies de la peau
US20050136116A1 (en) * 2003-12-18 2005-06-23 Keith Whitehead Stabilized prednisolone sodium phosphate solutions
AU2005207662B2 (en) * 2004-01-30 2011-08-04 Archimed Llp Wound dressings comprising hydrated hydrogels and enzymes
US20050255150A1 (en) * 2004-04-26 2005-11-17 Cassel Douglas R Wound treatment patch for alleviating pain
US20050276865A1 (en) * 2004-05-20 2005-12-15 Servet Buyuktimkin Peroxide compounds for the prevention and treatment of sexual dysfunction in humans
US7718674B2 (en) * 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
JP5219518B2 (ja) 2004-12-09 2013-06-26 ザ ファウンドリー， エルエルシー 大動脈弁修復
US8128952B2 (en) * 2005-01-12 2012-03-06 Clemson University Research Foundation Ligand-mediated controlled drug delivery
GB0505035D0 (en) * 2005-03-11 2005-04-20 Insense Ltd Improvements relating to skin dressings
US20060210613A1 (en) * 2005-03-15 2006-09-21 Carliss Richard D Therapeutic wound care product
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
US20070122362A1 (en) * 2005-11-26 2007-05-31 Giniger Martin S Hydrogel sheets and shapes for oral care
GB0524103D0 (en) * 2005-11-26 2006-01-04 Medical Res Council Healing
WO2007079193A2 (fr) 2005-12-30 2007-07-12 Tti Ellebeau, Inc. Systèmes iontophorétiques, dispositifs et procédés d'administration de principes actifs dans une interface biologique
GB0614278D0 (en) * 2006-07-19 2006-08-30 Insense Ltd Hydrogen peroxide delivery system
CA2655809C (fr) * 2006-07-21 2013-10-01 Bridge Pharma, Inc. Composes anesthesiques dermiques
WO2008023237A2 (fr) 2006-08-23 2008-02-28 Martin Wenckens Timbre transdermique pour expulser le venin d'insectes de la peau après de piqûres d'insectes membraneux (hyménoptères)
US8337883B2 (en) 2006-11-03 2012-12-25 Durect Corporation Transdermal delivery systems
US8093039B2 (en) * 2007-04-10 2012-01-10 The Trustees Of The Stevens Institute Of Technology Surfaces differentially adhesive to eukaryotic cells and non-eukaryotic cells
CA2690624A1 (fr) * 2007-07-23 2009-01-29 Hyperbranch Medical Technology, Inc. Materiaux de masquage polymeriques pour recouvrir des sites de plaie, et leurs procedes d'utilisation
JP2010539057A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療剤としてのヒト膵臓ポリペプチドの使用
US20090110656A1 (en) * 2007-10-31 2009-04-30 Lemke Sarah A Skin cooling composition
US20090157153A1 (en) * 2007-12-13 2009-06-18 Sarah Anne Lemke Skin cooling system
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
KR101057938B1 (ko) * 2008-09-30 2011-08-18 (주)바이오에프디엔씨 상처 치유 및 조직 재생을 위한 항염 화장료 조성물
CA2738524C (fr) 2008-10-02 2013-11-26 Mylan Inc. Procede de fabrication d'un stratifie adhesif multicouches
US10098857B2 (en) 2008-10-10 2018-10-16 The Board Of Trustees Of The Leland Stanford Junior University Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds
US20100092546A1 (en) * 2008-10-10 2010-04-15 Gurtner Geoffrey C Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds
MX352187B (es) * 2009-12-16 2017-11-13 Shasun Pharmaceuticals Ltd Star Composición novedosa de hidrogel transdérmico de dexibuprofeno.
CZ2010126A3 (cs) 2010-02-18 2011-04-20 Univerzita Tomáše Bati ve Zlíne Suchá substance hydrogelu pro krytí ran a zpusob její prípravy
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
CN102858321A (zh) * 2010-06-18 2013-01-02 莫茨药物股份两合公司 用于局部使用1-氨基-烷基环己烷衍生物的凝胶制剂
US9433580B2 (en) * 2011-07-21 2016-09-06 Sun Pharmaceutical Industries Limited Topical pharmaceutical composition comprising nanonized silver sulfadiazine
US20130267490A1 (en) * 2010-08-02 2013-10-10 Ranbaxy Laboratories Limited Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
WO2012064766A2 (fr) * 2010-11-09 2012-05-18 Jie Zhang Systèmes de combinaison d'un feuillet et d'un liquide destinés à administrer des médicaments par voie percutanée
WO2012077651A1 (fr) * 2010-12-07 2012-06-14 祐徳薬品工業株式会社 Timbre transdermique contenant un antidépresseur noradrénergique et sérotoninergique spécifique
JP5738588B2 (ja) * 2010-12-28 2015-06-24 花王株式会社 酸素供給シート
US20120259269A1 (en) 2011-04-08 2012-10-11 Tyco Healthcare Group Lp Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
US8911782B2 (en) * 2011-04-11 2014-12-16 Specialty Pharmaceutical Products Llc Transdermal patches having ionized beam crosslinked polymers and improved release characteristics
US20130022569A1 (en) * 2011-05-16 2013-01-24 Uhrich Kathryn E Hydrogels
US9321030B2 (en) 2012-01-04 2016-04-26 The Trustees Of The Stevens Institute Of Technology Clay-containing thin films as carriers of absorbed molecules
US20150110852A1 (en) * 2012-05-08 2015-04-23 Jie Zhang Sheet and liquid combination systems for dermal delivery of lidocaine, diclofenac, and other drugs
US20150148758A1 (en) * 2012-06-05 2015-05-28 Yutoku Pharmaceutical Industries Co., Ltd., Mirtazapine-containing transdermally-absorbable skin-adhesive preparation
WO2014194055A1 (fr) 2013-05-29 2014-12-04 Rutgers, The State University Of New Jersey Poly(anhydride-esters) à base d'antioxydants
WO2015127451A1 (fr) * 2014-02-24 2015-08-27 The Arizona Board Of Regents On Behalf Of The University Of Arizona Ligands multivalents/multifonctionnels présentant des activités d'agoniste au niveau de récepteurs d'opioïdes et des activités d'antagoniste au niveau du récepteur nk1 pour soulager la douleur
EP3137111A4 (fr) * 2014-05-02 2017-11-22 The Research Foundation of the State University of New York Compositions et méthodes d'administration de vaccins intradermiques
EP2946776A1 (fr) * 2014-05-20 2015-11-25 LTS LOHMANN Therapie-Systeme AG Système thérapeutique transdermique destiné à l'administration d'amitriptyline
EP3297620A4 (fr) * 2015-06-27 2019-01-09 Shenox Pharmaceuticals, LLC Système d'administration transdermique de la kétamine
US20180318279A1 (en) * 2015-10-23 2018-11-08 Rush University Medical Center Topical compositions providing pain relief and methods of use thereof
ES2861502T3 (es) * 2015-11-05 2021-10-06 Univ Louisville Res Found Inc Anestesia y analgesia locales y regionales
US20170273974A1 (en) * 2016-03-24 2017-09-28 Medrx Co., Ltd Patch preparations with misuse prevention features
US11331288B2 (en) 2017-09-14 2022-05-17 The Board Of Trustees Of The Leland Stanford Junior University Conditioning irradiated tissue for increasing vascularity
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
DE102017127433A1 (de) 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
US11116561B2 (en) 2018-01-24 2021-09-14 Medtronic Ardian Luxembourg S.A.R.L. Devices, agents, and associated methods for selective modulation of renal nerves
EP3955936A1 (fr) 2019-04-17 2022-02-23 COMPASS Pathfinder Limited Traitement de la dépression et de divers autres troubles au moyen de psilocybine
FR3108841B1 (fr) * 2020-04-06 2023-11-03 Algotherapeutix Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5143071A (en) * 1989-03-30 1992-09-01 Nepera, Inc. Non-stringy adhesive hydrophilic gels
CA2123487A1 (fr) * 1991-11-12 1993-05-27 Adrian S. Fox Hydrogels adhesifs possedant une duree de vie prolongee et methode de preparation
US5489624A (en) * 1992-12-01 1996-02-06 Minnesota Mining And Manufacturing Company Hydrophilic pressure sensitive adhesives
US5306504A (en) * 1992-12-09 1994-04-26 Paper Manufactures Company Skin adhesive hydrogel, its preparation and uses
US6211171B1 (en) * 1998-05-19 2001-04-03 Dalhousie University Use of antidepressants for local analgesia
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
WO2001041745A1 (fr) * 1999-12-10 2001-06-14 Lectec Corporation Patch antiprurigineux
SE9904750D0 (sv) * 1999-12-23 1999-12-23 Pharmacia & Upjohn Ab New formulation, use and method
US6455066B1 (en) * 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
WO2002089849A1 (fr) * 2001-05-07 2002-11-14 Corium International Compositions et systemes d'administration d'un anesthesique local

Also Published As

Publication number Publication date
MXPA04003589A (es) 2005-07-15
EP1441635A4 (fr) 2010-05-26
JP2005510488A (ja) 2005-04-21
WO2003034900A3 (fr) 2003-11-06
WO2003034900A2 (fr) 2003-05-01
KR20040048965A (ko) 2004-06-10
US20030082225A1 (en) 2003-05-01
CA2463309A1 (fr) 2003-05-01
EP1441635A2 (fr) 2004-08-04

Similar Documents

Publication Publication Date Title
IL161455A0 (en) Sterile, breathable patch for treating wound pain
AU2002342613A8 (en) Treatment for wounds
AP2210A (en) 4-tetrazolyl-4phenylpiperidine derivatives for treating pain.
AU2002302333A1 (en) Radio module, respirator, therapeutic device for carrying out cpap treatment and monitoring device therefor
GB0108671D0 (en) Skin treatment
AU751887B2 (en) Guide bar including stump treatment
AU9716001A (en) Guide bar including stump treatment
HK1064609A1 (en) 2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino alkyl -acid derivatives for the treatment of pain
GB0702859D0 (en) Dressing for tissue treatment
GB0106565D0 (en) Growth hormone treatment
AU5847299A (en) Medical device for treating narrow nostrils
GB2397018B (en) Combination therapy for treating disease
GB2378387B (en) Apparatus for beauty treatment
AU2002349330A1 (en) Yarn treatment device
AU2002365236A8 (en) Therapeutic use for lp229, in particular for wound healing
GB0102559D0 (en) Treatment for angiogenesis-dependant condition
GB0118977D0 (en) New medical treatment
AU2003206796A1 (en) Anti-microbial fabric treatment
CA92667S (en) Eye wrinkle treatment patch
CA92668S (en) Eye wrinkle treatment patch
GB0128813D0 (en) Medical treatment
GB0127271D0 (en) Medical treatment
GB0127267D0 (en) Medical treatment
GB0106983D0 (en) Medical treatment
AU145207S (en) Eye wrinkle treatment patch